Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

The Stability of the Anti-Müllerian Hormone in Serum and Plasma Samples under Various Preanalytical Conditions

R. Vrzáková, V. Šimánek, O. Topolčan, V. Vurm, D. Slouka, R. Kučera

. 2023 ; 13 (8) : . [pub] 20230421

Status not-indexed Language English Country Switzerland

Document type Journal Article

The anti-Müllerian hormone (AMH) is a glycoprotein that plays an important role in prenatal sex differentiation. It is used as a biomarker in polycystic ovary syndrome (PCOS) diagnostics, as well as for estimating an individual's ovarian reserve and the ovarian response to hormonal stimulation during in vitro fertilization (IVF). The aim of this study was to test the stability of AMH during various preanalytical conditions that are in accordance with the ISBER (International Society for Biological and Environmental Repositories) protocol. Plasma and serum samples were taken from each of the 26 participants. The samples were then processed according to the ISBER protocol. AMH levels were measured in all the samples simultaneously using the chemiluminescent kit ACCESS AMH in a UniCel® DxI 800 Immunoassay System (Beckman Coulter, Brea, CA, USA). The study proved that AMH retains a relatively high degree of stability during repeated freezing and thawing in serum. AMH was shown to be less stable in plasma samples. Room temperature proved to be the least suitable condition for the storage of samples before performing the biomarker analysis. During the testing of storage stability at 5-7 °C, the values decreased over time for all the plasma samples but remained stable in the serum samples. We proved that AMH is highly stable under various stress conditions. The anti-Müllerian hormone retained the greatest stability in the serum samples.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23009925
003      
CZ-PrNML
005      
20230721095410.0
007      
ta
008      
230707s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/diagnostics13081501 $2 doi
035    __
$a (PubMed)37189609
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Vrzáková, Radana $u Department of Chemistry and Biochemistry, Faculty of Medicine in Pilsen, Charles University, 32300 Pilsen, Czech Republic
245    14
$a The Stability of the Anti-Müllerian Hormone in Serum and Plasma Samples under Various Preanalytical Conditions / $c R. Vrzáková, V. Šimánek, O. Topolčan, V. Vurm, D. Slouka, R. Kučera
520    9_
$a The anti-Müllerian hormone (AMH) is a glycoprotein that plays an important role in prenatal sex differentiation. It is used as a biomarker in polycystic ovary syndrome (PCOS) diagnostics, as well as for estimating an individual's ovarian reserve and the ovarian response to hormonal stimulation during in vitro fertilization (IVF). The aim of this study was to test the stability of AMH during various preanalytical conditions that are in accordance with the ISBER (International Society for Biological and Environmental Repositories) protocol. Plasma and serum samples were taken from each of the 26 participants. The samples were then processed according to the ISBER protocol. AMH levels were measured in all the samples simultaneously using the chemiluminescent kit ACCESS AMH in a UniCel® DxI 800 Immunoassay System (Beckman Coulter, Brea, CA, USA). The study proved that AMH retains a relatively high degree of stability during repeated freezing and thawing in serum. AMH was shown to be less stable in plasma samples. Room temperature proved to be the least suitable condition for the storage of samples before performing the biomarker analysis. During the testing of storage stability at 5-7 °C, the values decreased over time for all the plasma samples but remained stable in the serum samples. We proved that AMH is highly stable under various stress conditions. The anti-Müllerian hormone retained the greatest stability in the serum samples.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Šimánek, Václav $u Department of Immunochemistry, University Hospital and Faculty of Medicine in Pilsen, Charles University, 32300 Pilsen, Czech Republic
700    1_
$a Topolčan, Ondřej $u Department of Immunochemistry, University Hospital and Faculty of Medicine in Pilsen, Charles University, 32300 Pilsen, Czech Republic
700    1_
$a Vurm, Vladimír $u Department of Immunochemistry, University Hospital and Faculty of Medicine in Pilsen, Charles University, 32300 Pilsen, Czech Republic
700    1_
$a Slouka, David $u Department of Otorhinolaryngology, University Hospital and Faculty of Medicine in Pilsen, Charles University, 30955 Pilsen, Czech Republic $1 https://orcid.org/0000000239887898 $7 xx0139295
700    1_
$a Kučera, Radek $u Department of Immunochemistry, University Hospital and Faculty of Medicine in Pilsen, Charles University, 32300 Pilsen, Czech Republic $u Department of Pharmacology and Toxicology, Faculty of Medicine in Pilsen, Charles University, 32300 Pilsen, Czech Republic $1 https://orcid.org/0000000227392302 $7 jo2016919265
773    0_
$w MED00195450 $t Diagnostics (Basel, Switzerland) $x 2075-4418 $g Roč. 13, č. 8 (2023)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37189609 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230707 $b ABA008
991    __
$a 20230721095404 $b ABA008
999    __
$a ok $b bmc $g 1958562 $s 1196189
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 13 $c 8 $e 20230421 $i 2075-4418 $m Diagnostics $n Diagnostics $x MED00195450
LZP    __
$a Pubmed-20230707

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...